Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH), 48690-48691 [2020-17552]

Download as PDF 48690 Federal Register / Vol. 85, No. 156 / Wednesday, August 12, 2020 / Notices A. Federal Reserve Bank of Minneapolis (Chris P. Wangen, Assistant Vice President), 90 Hennepin Avenue, Minneapolis, Minnesota 55480–0291: 1. The Williams Family Goose River Trust, James L. Williams III, as sole trustee, both of Casselton, North Dakota; to join the Williams Family Group, a group acting in concert, and to acquire voting shares of Goose River Holding Company, and thereby indirectly acquire shares of The Goose River Bank, both of Mayville, North Dakota. Board of Governors of the Federal Reserve System, August 7, 2020. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2020–17630 Filed 8–11–20; 8:45 am] BILLING CODE P Authority: National Defense Authorization Act (NDAA) for Fiscal Year 2019, Title VII, Section 889. Maria Swaby, GSA Procurement Ombudsman, General Services Administration. [FR Doc. 2020–17606 Filed 8–11–20; 8:45 am] BILLING CODE 6820–61–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC–2020–0092; NIOSH 278] Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting and request for comment. AGENCY: GENERAL SERVICES ADMINISTRATION Notice of Date Change for GSA Virtual Webinar regarding GSA’s Implementation of Section 889 of the FY 2019 National Defense Authorization Act (NDAA) Office of Governmentwide Policy (OGP), General Services Administration (GSA). AGENCY: ACTION: Meeting notice. The General Services Administration (GSA) previously announced in its July 22, 2020 Federal Register notice that it planned to hold a live and recorded virtual webinar on August 12, 2020. That virtual webinar date has been changed to September 10, 2020. SUMMARY: Thursday, September 10, 2020, at 1:00 p.m. Eastern Standard Time (EST). DATES: The webinar will be held virtually and the call-in information will be made available to registrants. Industry partners wishing to virtually attend must register at: https:// gsa.zoomgov.com/webinar/register/WN_ hQ6tHTRDR-mMNnRRxJy22Q. Members of the press, in addition to registering for this event, must also RSVP to press@gsa.gov by Tuesday, September 8, 2020. khammond on DSKJM1Z7X2PROD with NOTICES ADDRESSES: FOR FURTHER INFORMATION CONTACT: Patricia Richardson at patricia.m.richardson@gsa.gov or Maria Swaby at 202–208–0291. VerDate Sep<11>2014 16:37 Aug 11, 2020 Jkt 250001 In accordance with the Federal Advisory Committee Act, the CDC announces the following virtual meeting of the Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH). This meeting is open to the public via webcast and by teleconference. Time will be available for public comment. DATES: The meeting will be held on September 29, 2020, from 11 a.m.–4:15 p.m., EDT. If you wish to attend by webcast or teleconference, please register at the NIOSH website https://www.cdc.gov/ niosh/bsc/ or call (404–498–2581) no later than September 22, 2020. Written comments received by September 22, 2020 will be provided to the BSC prior to the meeting. Docket number CDC–2020–0092; NIOSH–278 will close September 29, 2020. ADDRESSES: You may submit comments, identified by Docket No. CDC–2020– 0092; NIOSH–278 by mail. CDC does not accept comments by email. • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. • Mail: Docket number CDC–2020– 0092; NIOSH–278, c/o Sherri Diana, NIOSH Docket Office, National Institute for Occupational Safety and Health, 1090 Tusculum Avenue, MS C–34, Cincinnati, Ohio 45226. Instructions: All submissions received must include the Agency name and Docket Number. Written public comments received by September 22, 2020 will be provided to the BSC prior SUMMARY: [Notice MV–2020–03; Docket No. 2020– 0002; Sequence No. 29] PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 to the meeting. Docket number CDC– 2020–0092; NIOSH–278 will close September 29, 2020. FOR FURTHER INFORMATION CONTACT: Emily J.K. Novicki, M.A., M.P.H., Executive Secretary, BSC, NIOSH, CDC, 1600 Clifton Ave., MS V24–4, Atlanta, GA 30329, telephone (404) 498–2581, or email at enovicki@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Secretary, the Assistant Secretary for Health, and by delegation the Director, Centers for Disease Control and Prevention, are authorized under Sections 301 and 308 of the Public Health Service Act to conduct directly or by grants or contracts, research, experiments, and demonstrations relating to occupational safety and health and to mine health. The Board of Scientific Counselors provides guidance to the Director, National Institute for Occupational Safety and Health on research and prevention programs. Specifically, the Board provides guidance on the Institute’s research activities related to developing and evaluating hypotheses, systematically documenting findings and disseminating results. The Board evaluates the degree to which the activities of the National Institute for Occupational Safety and Health: (1) Conform to appropriate scientific standards, (2) address current, relevant needs, and (3) produce intended results. Matters To Be Considered: The agenda for the meeting addresses occupational safety and health issues related to: Occupational Data for Health: Progress towards incorporating occupational information in electronic health records and health IT systems; Health Equity and the Paradigm Shift in Occupational Safety and Health; and Evaluation capacity building, a gateway to NIOSH’s future impact. An agenda is also posted on the NIOSH website (https:// www.cdc.gov/niosh/bsc/). Meeting Information: Adobe Connect webcast will be available at https:// odniosh.adobeconnect.com/nioshbsc/, and teleconference is available toll-free at (855) 644–0229, Participant Pass Code 9777483. This meeting is open to the public, limited only by the number of Adobe license seats available, which is 100. Public Participation Comments received are part of the public record and are subject to public disclosure. Do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other E:\FR\FM\12AUN1.SGM 12AUN1 48691 Federal Register / Vol. 85, No. 156 / Wednesday, August 12, 2020 / Notices information that identifies you in the body of your comments, that information will be on public display. CDC will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/ near duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted into the docket. CDC does not accept comment by email. Oral Public Comment: The public is welcome to participate during the public comment period, from 1:30 p.m. to 1:45 p.m., EDT, September 29, 2020. Please note that the public comment period ends at the time indicated above. Each commenter will be provided up to five minutes for comment. A limited number of time slots are available and will be assigned on a first come-first served basis. Members of the public who wish to address the NIOSH BSC are requested to contact the Executive Secretary for scheduling purposes (see FOR FUTHER INFORMATION above). Written Public Comment: Written comments will also be accepted from those unable to attend the public session per the instructions provided in the address section above. Written comments received in advance of the Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–17552 Filed 8–11–20; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–9125–N] Medicare and Medicaid Programs; Quarterly Listing of Program Issuances—April Through June 2020 Centers for Medicare & Medicaid Services (CMS), Health and Human Services (HHS). ACTION: Notice. AGENCY: This quarterly notice lists CMS manual instructions, substantive and interpretive regulations, and other Federal Register notices that were published from April through June 2020, relating to the Medicare and Medicaid programs and other programs administered by CMS. FOR FURTHER INFORMATION CONTACT: It is possible that an interested party may need specific information and not be able to determine from the listed information whether the issuance or regulation would fulfill that need. Consequently, we are providing contact persons to answer general questions concerning each of the addenda published in this notice. SUMMARY: Addenda Contact I. CMS Manual Instructions .............................................................................................................. II. Regulation Documents Published in the Federal Register ........................................................ III. CMS Rulings ................................................................................................................................ IV. Medicare National Coverage Determinations ............................................................................. V. FDA-Approved Category B IDEs ................................................................................................. VI. Collections of Information ........................................................................................................... VII. Medicare–Approved Carotid Stent Facilities .............................................................................. VIII. American College of Cardiology-National Cardiovascular Data Registry Sites ....................... IX. Medicare’s Active Coverage-Related Guidance Documents ...................................................... X. One-time Notices Regarding National Coverage Provisions ....................................................... XI. National Oncologic Positron Emission Tomography Registry Sites ........................................... XII. Medicare-Approved Ventricular Assist Device (Destination Therapy) Facilities ....................... XIII. Medicare–Approved Lung Volume Reduction Surgery Facilities ............................................. XIV. Medicare-Approved Bariatric Surgery Facilities ....................................................................... XV. Fluorodeoxyglucose Positron Emission Tomography for Dementia Trials ............................... All Other Information ......................................................................................................................... Ismael Torres ..................... Terri Plumb ......................... Tiffany Lafferty ................... Wanda Belle, MPA ............. John Manlove ..................... William Parham .................. Sarah Fulton, MHS ............ Sarah Fulton, MHS ............ JoAnna Baldwin, MS .......... JoAnna Baldwin, MS .......... David Dolan, MBA .............. David Dolan, MBA .............. Sarah Fulton, MHS ............ Sarah Fulton, MHS ............ David Dolan, MBA .............. Annette Brewer .................. SUPPLEMENTARY INFORMATION: khammond on DSKJM1Z7X2PROD with NOTICES meeting will be included in the official record of the meeting. Written comments received by September 22, 2020 will be provided to the BSC prior to the meeting. Docket number CDC– 2020–0092; NIOSH–278 will close September 29, 2020. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. I. Background The Centers for Medicare & Medicaid Services (CMS) is responsible for administering the Medicare and Medicaid programs and coordination and oversight of private health insurance. Administration and oversight of these programs involves the following: (1) Furnishing information to Medicare and Medicaid beneficiaries, health care providers, and the public; and (2) maintaining effective communications with CMS regional VerDate Sep<11>2014 16:37 Aug 11, 2020 Jkt 250001 offices, state governments, state Medicaid agencies, state survey agencies, various providers of health care, all Medicare contractors that process claims and pay bills, National Association of Insurance Commissioners (NAIC), health insurers, and other stakeholders. To implement the various statutes on which the programs are based, we issue regulations under the authority granted to the Secretary of the Department of Health and Human Services under sections 1102, 1871, 1902, and related provisions of the PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 Phone No. (410) (410) (410) (410) (410) (410) (410) (410) (410) (410) (410) (410) (410) (410) (410) (410) 786–1864 786–4481 786–7548 786–7491 786–6877 786–4669 786–2749 786–2749 786–7205 786–7205 786–3365 786–3365 786–2749 786–2749 786–3365 786–6580 Social Security Act (the Act) and Public Health Service Act. We also issue various manuals, memoranda, and statements necessary to administer and oversee the programs efficiently. Section 1871(c) of the Act requires that we publish a list of all Medicare manual instructions, interpretive rules, statements of policy, and guidelines of general applicability not issued as regulations at least every 3 months in the Federal Register. E:\FR\FM\12AUN1.SGM 12AUN1

Agencies

[Federal Register Volume 85, Number 156 (Wednesday, August 12, 2020)]
[Notices]
[Pages 48690-48691]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17552]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2020-0092; NIOSH 278]


Board of Scientific Counselors, National Institute for 
Occupational Safety and Health (BSC, NIOSH)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following virtual meeting of the Board of Scientific 
Counselors, National Institute for Occupational Safety and Health (BSC, 
NIOSH). This meeting is open to the public via webcast and by 
teleconference. Time will be available for public comment.

DATES: The meeting will be held on September 29, 2020, from 11 a.m.-
4:15 p.m., EDT.
    If you wish to attend by webcast or teleconference, please register 
at the NIOSH website https://www.cdc.gov/niosh/bsc/ or call (404-498-
2581) no later than September 22, 2020.
    Written comments received by September 22, 2020 will be provided to 
the BSC prior to the meeting. Docket number CDC-2020-0092; NIOSH-278 
will close September 29, 2020.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0092; NIOSH-278 by mail. CDC does not accept comments by email.
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Docket number CDC-2020-0092; NIOSH-278, c/o Sherri 
Diana, NIOSH Docket Office, National Institute for Occupational Safety 
and Health, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226.
    Instructions: All submissions received must include the Agency name 
and Docket Number. Written public comments received by September 22, 
2020 will be provided to the BSC prior to the meeting. Docket number 
CDC-2020-0092; NIOSH-278 will close September 29, 2020.

FOR FURTHER INFORMATION CONTACT: Emily J.K. Novicki, M.A., M.P.H., 
Executive Secretary, BSC, NIOSH, CDC, 1600 Clifton Ave., MS V24-4, 
Atlanta, GA 30329, telephone (404) 498-2581, or email at 
[email protected].

SUPPLEMENTARY INFORMATION:
    Purpose: The Secretary, the Assistant Secretary for Health, and by 
delegation the Director, Centers for Disease Control and Prevention, 
are authorized under Sections 301 and 308 of the Public Health Service 
Act to conduct directly or by grants or contracts, research, 
experiments, and demonstrations relating to occupational safety and 
health and to mine health. The Board of Scientific Counselors provides 
guidance to the Director, National Institute for Occupational Safety 
and Health on research and prevention programs. Specifically, the Board 
provides guidance on the Institute's research activities related to 
developing and evaluating hypotheses, systematically documenting 
findings and disseminating results. The Board evaluates the degree to 
which the activities of the National Institute for Occupational Safety 
and Health: (1) Conform to appropriate scientific standards, (2) 
address current, relevant needs, and (3) produce intended results.
    Matters To Be Considered: The agenda for the meeting addresses 
occupational safety and health issues related to: Occupational Data for 
Health: Progress towards incorporating occupational information in 
electronic health records and health IT systems; Health Equity and the 
Paradigm Shift in Occupational Safety and Health; and Evaluation 
capacity building, a gateway to NIOSH's future impact. An agenda is 
also posted on the NIOSH website (https://www.cdc.gov/niosh/bsc/).
    Meeting Information: Adobe Connect webcast will be available at 
https://odniosh.adobeconnect.com/nioshbsc/, and teleconference is 
available toll-free at (855) 644-0229, Participant Pass Code 9777483. 
This meeting is open to the public, limited only by the number of Adobe 
license seats available, which is 100.

Public Participation

    Comments received are part of the public record and are subject to 
public disclosure. Do not include any information in your comment or 
supporting materials that you consider confidential or inappropriate 
for public disclosure. If you include your name, contact information, 
or other

[[Page 48691]]

information that identifies you in the body of your comments, that 
information will be on public display. CDC will review all submissions 
and may choose to redact, or withhold, submissions containing private 
or proprietary information such as Social Security numbers, medical 
information, inappropriate language, or duplicate/near duplicate 
examples of a mass-mail campaign. CDC will carefully consider all 
comments submitted into the docket. CDC does not accept comment by 
email.
    Oral Public Comment: The public is welcome to participate during 
the public comment period, from 1:30 p.m. to 1:45 p.m., EDT, September 
29, 2020. Please note that the public comment period ends at the time 
indicated above. Each commenter will be provided up to five minutes for 
comment. A limited number of time slots are available and will be 
assigned on a first come-first served basis. Members of the public who 
wish to address the NIOSH BSC are requested to contact the Executive 
Secretary for scheduling purposes (see FOR FUTHER INFORMATION above).
    Written Public Comment: Written comments will also be accepted from 
those unable to attend the public session per the instructions provided 
in the address section above. Written comments received in advance of 
the meeting will be included in the official record of the meeting. 
Written comments received by September 22, 2020 will be provided to the 
BSC prior to the meeting. Docket number CDC-2020-0092; NIOSH-278 will 
close September 29, 2020.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-17552 Filed 8-11-20; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.